Primary hyperaldosteronism classification

	Primary hyperaldosteronism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Primary Hyperaldosteronism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
CT scan Findings
MRI Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Case Studies
Case #1
Primary hyperaldosteronism classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Primary hyperaldosteronism classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Primary hyperaldosteronism classification
CDC on Primary hyperaldosteronism classification
Primary hyperaldosteronism classification in the news
Blogs on Primary hyperaldosteronism classification
Directions to Hospitals Treating Conn syndrome
Risk calculators and risk factors for Primary hyperaldosteronism classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]

Overview

Primary hyperaldosteronism may be classified into five groups, including adrenal carcinoma, familial hyperaldosteronism type I and II, Idiopathic hyperaldosteronism (IH), primary adrenal hyperplasia, and aldosterone producing adenoma (APA), which is either renin-responsive or renin-unresponsive.

↑ Plouin, P.-F.; Amar, L.; Chatellier, G. (2004). "Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension". Nephrology Dialysis Transplantation. 19 (4): 774–777. doi:10.1093/ndt/gfh112. ISSN 0931-0509.
↑ Gordon, R.D. (1994). "Mineralocorticoid hypertension". The Lancet. 344 (8917): 240–243. doi:10.1016/S0140-6736(94)93003-1. ISSN 0140-6736.
↑ Phillips, John L.; Walther, McClellan M.; Pezzullo, John C.; Rayford, Walter; Choyke, Peter L.; Berman, Arlene A.; Linehan, W. Marston; Doppman, John L.; Gill Jr., John R. (2000). "Predictive Value of Preoperative Tests in Discriminating Bilateral Adrenal Hyperplasia from an Aldosterone-Producing Adrenal Adenoma". The Journal of Clinical Endocrinology & Metabolism. 85 (12): 4526–4533. doi:10.1210/jcem.85.12.7086. ISSN 0021-972X.